Clinical Trial Update: Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing nanoparticulate versus micronized steroid delivery for transdermal hormone replacement in menopausal syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Snippet

Sponsor: University Potiguar | Conditions: Menopausal Syndrome | Phase 2 | Status: COMPLETED